Jeff Pierce, DO
Pain Medicine · Livonia, MINPI 1235103771
Payments from drug & device makers
Across 36 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fidia Pharma USA Inc.$205
- Stimwave Technologies Incorporated$82
- Nevro Corp.$65
- Pfizer$58
- GRT US Holding, Inc.$43
- Pacira Pharmaceuticals Incorporated$36
- plus $288 from 13 others
What the payments were for
- Food & beverage$778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fidia Pharma USA Inc. | 9 | $205 |
| Stimwave Technologies Incorporated | 1 | $82 |
| Nevro Corp. | 3 | $65 |
| Pfizer | 3 | $58 |
| GRT US Holding, Inc. | 3 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $36 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| Si-bone, Inc. | 1 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| Pacira Therapeutics, Inc. | 1 | $27 |
| Virtus Pharmaceuticals LLC | 2 | $27 |
| ERMI LLC | 2 | $26 |
| Boston Scientific | 1 | $21 |
| Medtronic | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Pinnacle, Inc | 1 | $14 |
| AbbVie | 1 | $14 |
| Amgen | 1 | $14 |
| Bioventus LLC | 1 | $12 |
How this compares
$778 in reported general payments places this provider in the 35th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 567 | $10,947 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 174 | $4,464 |
| Pregabalin | 108 | $3,564 |
| Gabapentin | 203 | $2,114 |
| Fentanyl | 19 | $1,383 |
| Diclofenac Sodium | 69 | $1,175 |
| Oxycodone Hcl | 29 | $556 |
| Duloxetine Hcl | 41 | $530 |
| Celecoxib | 43 | $529 |
| Meloxicam | 108 | $460 |
| Tizanidine Hcl | 75 | $431 |
| Methocarbamol | 46 | $419 |
| Tramadol Hcl | 68 | $361 |
| Cyclobenzaprine Hcl | 68 | $190 |
| Ibuprofen | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Livonia
- Ayman TarabishyLivonia$16K
- Timothy BazilLivonia$3K
- Joel SaperAnn Arbor$5.7M
- Harry SukumaranRochester Hills$308K
- Bindu Popat LewisGrand Rapids$135K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$72K
- Alexander TurfeWyandotte$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.